© Quickmeme
Two months and one day after it was
sued, and close to 3 months since it licensed Pfizer's Covid-19 vaccine, the FDA released the first round of documents it reviewed before licensing this product. The production consisted of 91 pdf pages, one xpt file, and one txt file. You can download them
here.
While it is for the scientists to properly analyze, let me share one observation. One of the documents produced is a
Cumulative Analysis of Post-Authorization Adverse Event Reports of [the Vaccine] Received Through 28-Feb-2021, which is a mere 2 ½ months after the vaccine received emergency use authorization (EUA). This document reflects adverse events following vaccination that have completed Pfizer's "workflow cycle," both in and outside the U.S., up to February 28, 2021.
Pfizer explains, on page 6, that
"Due to the large numbers of spontaneous adverse event reports received for the product, [Pfizer] has prioritised the processing of serious cases..." and that Pfizer "has also taken a [sic] multiple actions to help alleviate the large increase of adverse event reports" including "increasing the number of data entry and case processing colleagues" and "has onboarded approximately [REDACTED] additional fulltime employees (FTEs)." Query why it is proprietary to share how many people Pfizer had to hire to track all of the adverse events being reported shortly after launching its product.
As for the volume of reports, in the 2 ½ months following EUA, Pfizer received a total of 42,086 reports containing 158,893 "events." Most of these reports were from the U.S. and
disproportionately involved women (29,914 vs. 9,182 provided by men) and those between 31 and 50 years old (13,886 vs 21,325 for all other age groups combined, with another 6,876 whose ages were unknown).
Also, 25,957 of the events were classified as "Nervous system disorders"
Comment: See also: The mRNA-experimental gene-altering poisonous jabs: Are they disguising the mRNA jabs as flu shots?